Literature DB >> 1315940

A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro.

R D Pinnock1.   

Abstract

Intracellular recordings were made from neurons in a rat locus coeruleus slice preparation in vitro. A postsynaptic potential was evoked by electrical stimulation of afferents to the neurons. CI-977 ([5R-(5a,7a,8b)]-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec -8-yl[-4-benzofuranacetamide monohydrochloride) caused a depression of the evoked postsynaptic potential on locus coeruleus neurons. This action was reversed on washout. Bremazocine had a similar action on less than 50% of locus coeruleus neurons. Concentrations of CI-977 which depressed the postsynaptic potential did not affect either passive membrane conductance or a voltage-sensitive potassium current resembling IA. The depression of the excitatory postsynaptic potential caused by CI-977 remained in the presence of either 30 microM bicuculline and picrotoxin or when potassium acetate-filled recording electrodes were used. Using potassium chloride-filled recording electrodes and in the presence of 30 microM 6-cyano-2,3-dihydro-7-nitroquinoxaline-2,3-dione and either 30 microM DL-2-amino-5-phosphonovaleric acid or 500 microM kynurenic acid, CI-977 had no effect on the postsynaptic potential. The effects of CI-977 were reversed by 30-100 nM naloxone and 1-10 nM norbinaltorphimine but not by 1-10 nM naloxone. The hyperpolarizing response to the mu-opioid receptor-selective agonist D-Ala2,Nme Phe4,Gly-ol5 (DAGOL) was blocked by 1-10 nM naloxone but not by 1-100 nM norbinaltorphimine. The hyperpolarizing response to DAGOL was not affected by high doses of CI-977.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315940     DOI: 10.1016/0306-4522(92)90123-j

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

3.  Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum.

Authors:  M P Hill; J M Brotchie
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Kappa Opioid Receptor Agonist and Brain Ischemia.

Authors:  Chen Chunhua; Xi Chunhua; Sugita Megumi; Liu Renyu
Journal:  Transl Perioper Pain Med       Date:  2014

5.  Effects of the Hybridization of Opioid and Neurotensin Pharmacophores on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Patrycja Kleczkowska; Maria Kawalec; Magdalena Bujalska-Zadrozny; Małgorzata Filip; Barbara Zablocka; Andrzej W Lipkowski
Journal:  Neurotox Res       Date:  2015-08-19       Impact factor: 3.911

6.  Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus.

Authors:  B A S Reyes; A D Johnson; J D Glaser; K G Commons; E J Van Bockstaele
Journal:  Neuroscience       Date:  2007-02-07       Impact factor: 3.590

Review 7.  The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

Authors:  E J Van Bockstaele; B A S Reyes; R J Valentino
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

Review 8.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

9.  Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine.

Authors:  J C Hunter; P Atwal; G N Woodruff; L Singh
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

10.  Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus.

Authors:  B A S Reyes; Charles Chavkin; E J van Bockstaele
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.